StonvexLoading…
StonvexStonvexStonvexCore line items from NXPI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.27B | $12.61B | $13.28B | $13.21B |
Operating Income | $3.05B | $3.42B | $3.66B | $3.80B |
Net Income | $2.02B | $2.51B | $2.80B | $2.79B |
EPS (Diluted) | $7.95 | $9.73 | $10.70 | $10.55 |
Total Assets | $26.56B | $24.39B | $24.35B | $23.24B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $3.27B | $3.29B | $3.86B | $3.85B |
Free Cash Flow OCF − CapEx | $2.42B | $2.06B | $2.69B | $2.83B |
Shares Outstanding | 254.33M | 257.85M | 261.37M | 264.05M |